Source: New York Post
Type 2 diabetes patients taking Ozempic and Wegovy may be getting an unexpected perk: a little extra backbone. A new study suggests semaglutide — the active ingredient in the blockbuster weight-loss drugs — could help strengthen bones in type 2 diabetes sufferers, even as it melts the pounds away, according to a Science Daily report. Researchers found that type 2 diabetes patients taking semaglutide were 15% less likely to suffer bone fractures than patients using other popular weight-loss medications.
Aller á la Source
Nouvelles connexes
